Erratum to: Marek's disease virus-encoded microRNAs: Genomics, expression and function (SCIENCE CHINA Life Sciences, (2010), 53, 10 (1174-1180), 10.1007/s11427-010-4073-6);Marek's disease virus-encoded microRNAs: Genomics, expression and function

Science China Life Sciences

Volumn 53, Issue 10, 2010, Pages 1174-1180

  Luo, Jun ^a   Teng, Man ^a   Fan, Jian Ming ^a,b   Wang, Fang Yu ^a   Zhou, Ling ^a   Deng, Rui Guang ^a   Zhang, Gai Ping ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

cancer; herpesvirus; MDV; miRNA; tumorigenesis

Indexed keywords

GALLID HERPESVIRUS 2; HERPESVIRIDAE; MARDIVIRUS;

EID: 77958473920     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-010-4113-2     Document Type: Erratum

References (37)

1. Bartel D P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 2004, 116: 281-297.
2. Filipowicz W, Bhattacharyya S N, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet, 2008, 9: 102-114.
3. Lee R C, Feinbaum R L, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 1993, 75: 843-854.
4. Wightman B, Ha I, Ruvkun G, et al. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell, 1993, 75: 855-862.
5. Griffiths-Jones S. The microRNA registry. Nucl Acids Res, 2004, 32: D109-D111.
6. Fabbri M, Garzon R, Andreeff M, et al. MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications. Leukemia, 2008, 22: 1095-1105.
7. Lee Y S, Dutta A. MicroRNAs in cancer. Annu Rev Pathol, 2009, 4: 199-227.
8. Sullivan C S, Ganem D. MicroRNAs and viral infection. Mol Cell, 2005, 20: 3-7.
9. Boss I W, Plaisance K B, Renne R. Role of virus-encoded microRNAs in herpesvirus biology. Trends Microbiol, 2009, 17: 544-553.
10. Witter R L, Schat K. Marek's disease. In: Saif Y M, ed. Diseases of Poultry. 11th ed. Ames: Iowa State University Press, 2003. 407-464.
11. Marek J. Multiple nervenentzuendung (polyneuritis) bei huehnern. Dtsch Tierarztl Wochenschr, 1907, 15: 417-421.
12. Lupiani B, Lee L F, Cui X, et al. Marek's disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication. Proc Natl Acad Sci USA, 2004, 101: 11815-11820.
13. Nair V, Kung H J. Marek's disease virus oncogenicity: molecular mechanisms. In: Davison F, Nair V, ed. Marek's Disease, an Evolving Problem. Oxford: Elsevier Academic Press, 2004. 32-48.
14. Burnside J, Bernberg E, Anderson A, et al. Marek's disease virus encodes MicroRNAs that map to meq and the latency-associated transcript. J Virol, 2006, 80: 8778-8786.
15. Yao Y, Zhao Y, Xu H, et al. Marek's disease virus type 2 (MDV-2)-encoded microRNAs show no sequence conservation with those encoded by MDV-1. J Virol, 2007, 81: 7164-7170.
16. Yao Y, Zhao Y, Xu H, et al. MicroRNA profile of Marek's disease virus-transformed T-cell line MSB-1: predominance of virus-encoded microRNAs. J Virol, 2008, 82: 4007-4015.
17. Waidner L A, Morgan R W, Anderson A S, et al. MicroRNAs of Gallid and Meleagrid herpesviruses show generally conserved genomic locations and are virus-specific. Virology, 2009, 388: 128-136.
18. Yao Y, Zhao Y, Smith L P, et al. Novel microRNAs (miRNAs) encoded by herpesvirus of Turkeys: evidence of miRNA evolution by duplication. J Virol, 2009, 83: 6969-6973.
19. Zhao Y, Yao Y, Xu H, et al. A functional MicroRNA-155 ortholog encoded by the oncogenic Marek's disease virus. J Virol, 2009, 83: 489-492.
20. Lambeth L S, Yao Y, Smith L P, et al. MicroRNAs 221 and 222 target p27Kip1 in Marek's disease virus-transformed tumour cell line MSB-1. J Gen Virol, 2009, 90: 1164-1171.
21. Cebrian J, Kaschka-Dierich C, Berthelot N, et al. Inverted repeat nucleotide sequences in the genomes of Marek's disease virus and the herpesvirus of the turkey. Proc Natl Acad Sci USA, 1982, 79: 555-558.
22. Osterrieder N, Kamil J P, Schumacher D, et al. Marek's disease virus: from miasma to model. Nat Rev Microbiol, 2006, 4: 283-294.
23. Morgan R, Anderson A, Bernberg E, et al. Sequence conservation and differential expression of Marek's disease virus microRNAs. J Virol, 2008, 82: 12213-12220.
24. Jones D, Lee L, Liu J L, et al. Marek's disease virus encodes a basic-leucine zipper gene resembling the fos/jun oncogenes that is highly expressed in lymphoblastoid tumors. Proc Natl Acad Sci USA, 1992, 89: 4042-4046.
25. Lee L F, Nazerian K, Boezi J A. Marek's disease virus DNA in a chicken lymphoblastoid cell line (MSB-1) and in virus-induced tumours. In: de Thé G, Epstein M A, Zur Hausen H, eds. Oncogenesis and Herpesviruses II. Lyon: International Agency for Research on Cancer, 1975. 199-204.
26. Sugaya K, Bradley G, Nonoyama M, et al. Latent transcripts of Marek's disease virus are clustered in the short and long repeat regions. J Virol, 1990, 64: 5773-5782.
27. Jarosinski K W, Osterrieder N, Nair V K, et al. Attenuation of Marek's disease virus by deletion of open reading frame RLORF4 but not RLORF5a. J Virol, 2005, 79: 11647-11659.
28. Schat K A, Hooft van Iddekinge B J L, Boerrigter H, et al. Open reading frame L1 of Marek's disease herpesvirus is not essential for in vitro and in vivo replication and establishment of latency. J Gen Virol, 1998, 79: 841-849.
29. Fornari F, Gramantieri L, Ferracin M, et al. MiR-221 controls CDKN1C//p57 and CDKN1B//p27 expression in human hepatocellular carcinoma. Oncogene, 2008, 27: 5651-5661.
30. Galardi S, Mercatelli N, Giorda E, et al. miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem, 2007, 282: 23716-23724.
31. Morgan R W, Xie Q, Cantello J L, et al. Marek's disease virus latency. Curr Top Microbiol Immunol, 2001, 255: 223-243.
32. Cantello J, Anderson A, Morgan R. Identification of latency-associated transcripts that map antisense to the ICP4 homolog gene of Marek's disease virus. J Virol, 1994, 68: 6280-6290.
33. Cantello J, Parcells M, Anderson A, et al. Marek's disease virus latency-associated transcripts belong to a family of spliced RNAs that are antisense to the ICP4 homolog gene. J Virol, 1997, 71: 1353-1361.
34. Schumacher D, Tischer B K, Fuchs W, et al. Reconstitution of Marek's disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant. J Virol, 2000, 74: 11088-11098.
35. Petherbridge L, Homes K, Baigent S J, et al. Replication-competent bacterial artificial chromosomes of Marek's disease virus: novel tools for generation of molecularly defined herpesvirus vaccines. J Virol, 2003, 77: 8712-8718.
36. Petherbridge L, Brown A C, Baigent S J, et al. Oncogenicity of virulent Marek's disease virus cloned as bacterial artificial chromosomes. J Virol, 2004, 78: 13376-13380.
37. Sun A J, Petherbridge L, Zhao Y G, et al. A BAC clone of MDV strain GX0101 with REV-LTR integration retained its pathogenicity. Chin Sci Bull, 2009, 54: 2641-2647.